Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Study of HT-ALZ shows decrease in Abeta in Alzheimer's disease mouse model after acute treatment

Jan. 5, 2022

Grant supports Cognition's evaluation of sigma-2 receptor modulators for Parkinson's disease

Jan. 5, 2022

Biogen exercises option to license preclinical ASO for spinal muscular atrophy

Jan. 5, 2022

Merck & Co. synthesizes RIPK1 inhibitors

Jan. 5, 2022

Novartis presents new Cav1.2 activators

Jan. 5, 2022

Amgen discloses new SCN9A blockers

Jan. 5, 2022

Ovid licenses KCC2 transporter activators from AstraZeneca

Jan. 4, 2022

Discovery of triple-action inhibitor for the treatment of neurodegenerative diseases

Jan. 4, 2022

Carnitine metabolite has role in cognitive aging

Dec. 31, 2021

Changing splicing lowers mutant Huntingtin

Dec. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...